{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:41:21Z","timestamp":1776422481937,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pfizer Austria","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12253-016-0157-3","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T05:38:39Z","timestamp":1481953119000},"page":"595-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-2070","authenticated-orcid":false,"given":"Lisa","family":"Arzt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Halbwedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Gogg-Kamerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut H.","family":"Popper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"issue":"3","key":"157_CR1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.seminoncol.2005.02.010","volume":"32","author":"NJ Vogelzang","year":"2005","unstructured":"Vogelzang NJ, Porta C, Mutti L (2005) New agents in the management of advanced mesothelioma. Semin Oncol 32(3):336\u2013350","journal-title":"Semin Oncol"},{"issue":"Pt 8","key":"157_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA (2004) The JAK\/STAT signaling pathway. J Cell Sci 117(Pt 8):1281\u20131283. doi:\n10.1242\/jcs.00963","journal-title":"J Cell Sci"},{"issue":"4","key":"157_CR3","first-page":"840","volume":"58","author":"A Buard","year":"1998","unstructured":"Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC (1998) Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma. Cancer Res 58(4):840\u2013847","journal-title":"Cancer Res"},{"issue":"4","key":"157_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/thx.2007.085241","volume":"63","author":"H Kothmaier","year":"2008","unstructured":"Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE, Murer B, Cagle PT, Attanoos R, Gibbs AR, Galateau-Salle F, Popper HH (2008) EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors. Thorax 63(4):345\u2013351. doi:\n10.1136\/thx.2007.085241","journal-title":"Thorax"},{"issue":"1","key":"157_CR5","first-page":"38","volume":"4","author":"L Arzt","year":"2011","unstructured":"Arzt L, Kothmaier H, Quehenberger F, Halbwedl I, Popper HH (2011) STAT signalling in malignant mesothelioma: is there a regulatory effect of microRNAs? Magazine of European. Med Oncol 4(1):38\u201342","journal-title":"Med Oncol"},{"issue":"2","key":"157_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/jcp.10364","volume":"197","author":"V Calo","year":"2003","unstructured":"Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197(2):157\u2013168. doi:\n10.1002\/jcp.10364","journal-title":"J Cell Physiol"},{"issue":"8","key":"157_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nri1885","volume":"6","author":"NC Reich","year":"2006","unstructured":"Reich NC, Liu L (2006) Tracking STAT nuclear traffic. Nat Rev Immunol 6(8):602\u2013612. doi:\n10.1038\/nri1885","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"157_CR8","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1073\/pnas.0801794105","volume":"105","author":"I Sadzak","year":"2008","unstructured":"Sadzak I, Schiff M, Gattermeier I, Glinitzer R, Sauer I, Saalmuller A, Yang E, Schaljo B, Kovarik P (2008) Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc Natl Acad Sci U S A 105(26):8944\u20138949. doi:\n10.1073\/pnas.0801794105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"157_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08977190500178745","volume":"23","author":"A Stephanou","year":"2005","unstructured":"Stephanou A, Latchman DS (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23(3):177\u2013182. doi:\n10.1080\/08977190500178745","journal-title":"Growth Factors"},{"issue":"10","key":"157_CR10","first-page":"845","volume":"92","author":"L Espert","year":"2005","unstructured":"Espert L, Dusanter-Fourt I, Chelbi-Alix MK (2005) Negative regulation of the JAK\/STAT: pathway implication in tumorigenesis. Bull Cancer 92(10):845\u2013857","journal-title":"Bull Cancer"},{"issue":"2","key":"157_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1074\/jbc.R300030200","volume":"279","author":"S Wormald","year":"2004","unstructured":"Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279(2):821\u2013824. doi:\n10.1074\/jbc.R300030200","journal-title":"J Biol Chem"},{"issue":"1","key":"157_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00428-014-1584-8","volume":"465","author":"L Arzt","year":"2014","unstructured":"Arzt L, Kothmaier H, Halbwedl I, Quehenberger F, Popper HH (2014) Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma. Virchows Arch 465(1):79\u201388. doi:\n10.1007\/s00428-014-1584-8","journal-title":"Virchows Arch"},{"issue":"1","key":"157_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1755-8417-2-7","volume":"2","author":"N Meola","year":"2009","unstructured":"Meola N, Gennarino VA, Banfi S (2009) microRNAs and genetic diseases. PathoGenetics 2(1):7. doi:\n10.1186\/1755-8417-2-7","journal-title":"PathoGenetics"},{"issue":"18","key":"157_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368(18):1685\u20131694. doi:\n10.1056\/NEJMoa1209026","journal-title":"N Engl J Med"},{"key":"157_CR15","unstructured":"Clinicaltrials.gov (2013) A Multicenter Phase I Study of MRX34. \nhttp:\/\/clinicaltrials.gov\/show\/NCT01829971"},{"issue":"1","key":"157_CR16","first-page":"23","volume":"68","author":"T Ueno","year":"2014","unstructured":"Ueno T, Toyooka S, Fukazawa T, Kubo T, Soh J, Asano H, Muraoka T, Tanaka N, Maki Y, Shien K, Furukawa M, Sakaguchi M, Yamamoto H, Tsukuda K, Miyoshi S (2014) Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural mesothelioma. Acta Med Okayama 68(1):23\u201326","journal-title":"Acta Med Okayama"},{"issue":"2","key":"157_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.yexmp.2011.05.007","volume":"91","author":"L Arzt","year":"2011","unstructured":"Arzt L, Kothmaier H, Quehenberger F, Halbwedl I, Wagner K, Maierhofer T, Popper HH (2011) Evaluation of formalin-free tissue fixation for RNA and microRNA studies. Exp Mol Pathol 91(2):490\u2013495. doi:\n10.1016\/j.yexmp.2011.05.007","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"157_CR18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","volume":"59","author":"HI Pass","year":"1995","unstructured":"Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ (1995) Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 59(4):835\u2013844","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"157_CR19","first-page":"3199","volume":"47","author":"FR Reale","year":"1987","unstructured":"Reale FR, Griffin TW, Compton JM, Graham S, Townes PL, Bogden A (1987) Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res 47(12):3199\u20133205","journal-title":"Cancer Res"},{"key":"157_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1476-4598-9-314","volume":"9","author":"A Shukla","year":"2010","unstructured":"Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT (2010) Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer 9:314. doi:\n10.1186\/1476-4598-9-314","journal-title":"Mol Cancer"},{"key":"157_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2407-10-142","volume":"10","author":"GB Lesinski","year":"2010","unstructured":"Lesinski GB, Zimmerer JM, Kreiner M, Trefry J, Bill MA, Young GS, Becknell B, Carson WE 3rd (2010) Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer 10:142. doi:\n10.1186\/1471-2407-10-142","journal-title":"BMC Cancer"},{"issue":"9","key":"157_CR22","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1096\/fj.08-106831","volume":"22","author":"S Madonna","year":"2008","unstructured":"Madonna S, Scarponi C, De Pita O, Albanesi C (2008) Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1\/2 activation. FASEB J 22(9):3287\u20133297. doi:\n10.1096\/fj.08-106831","journal-title":"FASEB J"},{"issue":"2","key":"157_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/156800906776056491","volume":"6","author":"L Klampfer","year":"2006","unstructured":"Klampfer L (2006) Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 6(2):107\u2013121","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"157_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ijc.27611","volume":"132","author":"K Iwahori","year":"2013","unstructured":"Iwahori K, Serada S, Fujimoto M, Ripley B, Nomura S, Mizuguchi H, Shimada K, Takahashi T, Kawase I, Kishimoto T, Naka T (2013) SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer 132(2):459\u2013471. doi:\n10.1002\/ijc.27611","journal-title":"Int J Cancer"},{"issue":"1","key":"157_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1\u201312. doi:\n10.1016\/j.ydbio.2006.08.028","journal-title":"Dev Biol"},{"issue":"7","key":"157_CR26","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257\u20132261. doi:\n10.1073\/pnas.0510565103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"157_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","volume":"42","author":"S Busacca","year":"2010","unstructured":"Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G (2010) MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 42(3):312\u2013319. doi:\n10.1165\/rcmb.2009-0060OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"157_CR28","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","volume":"24","author":"G Reid","year":"2013","unstructured":"Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, Brahmbhatt H, MacDiarmid JA, van Zandwijk N (2013) Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann Oncol: Off J Eur Soc Med Oncol\/ESMO 24(12):3128\u20133135. doi:\n10.1093\/annonc\/mdt412","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ESMO"},{"key":"157_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1584-5","author":"A Truini","year":"2014","unstructured":"Truini A, Coco S, Alama A, Genova C, Sini C, Dal Bello MG, Barletta G, Rijavec E, Burrafato G, Boccardo F, Grossi F (2014) Role of microRNAs in malignant mesothelioma. Cell Mol life Sci: CMLS. doi:\n10.1007\/s00018-014-1584-5","journal-title":"Cell Mol life Sci: CMLS"},{"issue":"40","key":"157_CR30","doi-asserted-by":"publisher","first-page":"41679","DOI":"10.1074\/jbc.M406413200","volume":"279","author":"Y Qing","year":"2004","unstructured":"Qing Y, Stark GR (2004) Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279(40):41679\u201341685. doi:\n10.1074\/jbc.M406413200","journal-title":"J Biol Chem"},{"key":"157_CR31","unstructured":"NCBI F2R coagulation factor II (thrombin) receptor \nhttp:\/\/www.ncbi.nlmnih.gov\/gene\/2149"},{"key":"157_CR32","unstructured":"NCBI JUN proto-oncogene. \nhttp:\/\/www.ncbi.nlmnih.gov\/gene\/3725"},{"key":"157_CR33","unstructured":"NCBI CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1). \nhttp:\/\/www.ncbi.nlmnih.gov\/gene\/1026"},{"issue":"6","key":"157_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1134\/S000629791206003X","volume":"77","author":"VS Romanov","year":"2012","unstructured":"Romanov VS, Pospelov VA, Pospelova TV (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry. Biokhimiia 77(6):575\u2013584. doi:\n10.1134\/S000629791206003X","journal-title":"Biokhimiia"},{"issue":"4","key":"157_CR35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75(4):817\u2013825","journal-title":"Cell"},{"issue":"35","key":"157_CR36","doi-asserted-by":"publisher","first-page":"32507","DOI":"10.1074\/jbc.M212517200","volume":"278","author":"K Lohr","year":"2003","unstructured":"Lohr K, Moritz C, Contente A, Dobbelstein M (2003) p21\/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278(35):32507\u201332516. doi:\n10.1074\/jbc.M212517200","journal-title":"J Biol Chem"},{"issue":"16","key":"157_CR37","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/sj.onc.1202632","volume":"18","author":"Y Wang","year":"1999","unstructured":"Wang Y, Blandino G, Givol D (1999) Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 18(16):2643\u20132649. doi:\n10.1038\/sj.onc.1202632","journal-title":"Oncogene"},{"issue":"6","key":"157_CR38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0955-0674(02)00381-2","volume":"14","author":"JM Adams","year":"2002","unstructured":"Adams JM, Cory S (2002) Apoptosomes: engines for caspase activation. Curr Opin Cell Biol 14(6):715\u2013720","journal-title":"Curr Opin Cell Biol"},{"key":"157_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","volume":"68","author":"WC Earnshaw","year":"1999","unstructured":"Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383\u2013424. doi:\n10.1146\/annurev.biochem.68.1.383","journal-title":"Annu Rev Biochem"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0157-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T02:33:57Z","timestamp":1496111637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0157-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0157-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}